A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

Clinical trial NCT07174583 · RECRUITING

Trial details

NCT number: NCT07174583
Sponsor: IDEAYA Biosciences
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer Neuroendocrine Carcinomas Solid Tumor Show to Express DLL3

Start date: 2025-10-14
Primary completion: 2029-07-01
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.